Drug Profile
Research programme: tumour necrosis factor/interleukin 6 inhibitor - Bone Medical
Alternative Names: BN 006Latest Information Update: 26 Jan 2016
Price :
$50
*
At a glance
- Originator Bone Medical
- Developer Bone Medical; Institute of Bone & Joint Research; William Harvey Research Institute
- Class Antirheumatics; Peptides
- Mechanism of Action Interleukin 6 inhibitors; Macrophage inhibitors; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Rheumatoid arthritis